Sivkova, N., Koleva-Georgieva, D. Bevacizumab for the treatment of macular oedema in patients with diabetic retinopathy and retinal vascular occlusive disorders,
, .
Sivkova, N., Koleva-Georgieva, D. .
Bevacizumab for the treatment of macular oedema in patients with diabetic retinopathy and retinal vascular occlusive disorders.
: , .
Sivkova, N., Koleva-Georgieva, D. ()
Bevacizumab for the treatment of macular oedema in patients with diabetic retinopathy and retinal vascular occlusive disorders,
:
Sivkova, N., & Koleva-Georgieva, D.
().
Bevacizumab for the treatment of macular oedema in patients with diabetic retinopathy and retinal vascular occlusive disorders. Autonomic & Autocoid Pharmacology; Autonomic & Autocoid Pharmacology.